Le Lézard
Classified in: Health
Subjects: FDA, PET, ANW

AVMA President to testify before Congress


AVMA working with lawmakers to increase the number of approved animal drugs

WASHINGTON, March 29, 2023 /PRNewswire/ -- Dr. Lori Teller, AVMA President, will testify before the House Energy and Commerce Subcommittee on Health on March 30, 2023, at 9:00 AM ET to discuss the importance of reauthorizing the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA). The legislation is up for reauthorization every five years and is critical to ensuring a predictable pathway to market for new and innovative animal drugs and generic animal drugs.

The AVMA supports the collection and effective utilization of user fees to enhance the U.S. Food and Drug Administration Center for Veterinary Medicine's (FDA CVM) review and approval of pioneer and generic animal drugs. Throughout 2022, the AVMA provided verbal and written comments to the FDA CVM regarding the needs of veterinarians in the reauthorization of these programs.

"Veterinarians need additional new, innovative, and generic animal drugs that have been demonstrated to be safe and effective to help protect animal and public health," said Dr. Teller. "We support the collection of user fees for new and generic animal drug applications when they are used to expedite the review and approval process for these products. The AVMA is grateful for this opportunity to highlight how critical the ADUFA and AGDUFA programs are to veterinarians in addressing the need for more safe, effective, and approved animal drugs for the benefit of our patients, their owners, and communities across the country."

Past animal drug user fee agreements have advocated for improved efficiency of the animal drug review and approval process; however, more can be done. The AVMA supports:

About the AVMA:

The AVMA is the nation's leading representative of the veterinary profession, speaking for more than 100,000 member veterinarians who care passionately about protecting animal health, animal welfare, and human health. Informed by its members' unique scientific training and knowledge, the AVMA advocates for policies that advance the practice of veterinary medicine and support the crucial work of veterinarians.

FOR MORE INFORMATION
Colin MacCarthy
Advocacy Communications Manager
American Veterinary Medical Association
Cell/Text: 202-641-2533
[email protected]

SOURCE American Veterinary Medical Association


These press releases may also interest you

at 15:06
Info-Tech Research Group's latest industry research outlines the revolutionary potential of AI to personalize healthcare and offers key strategies for integrating AI-powered precision medicine into healthcare systems. The newly published blueprint...

at 15:00
MemorialCare Medical Group has been awarded a 4.5 Star rating out of 5 Stars by the Integrated Healthcare Association (IHA), reflecting its commitment to excellence in healthcare delivery. This recognition is based on MemorialCare Medical Group's...

at 14:53
Rails to Trails Conservancy's annual nationwide celebration of trails, hosted on April 27, 2024, underscored the importance of connected walking and biking infrastructure to the well-being of people, places and the planet. Findings from the event,...

at 14:50
According to Arizton's latest research report, the air shower market will grow at a CAGR of 4.82% from 2023-2029. To Know More, Click: https://www.arizton.com/market-reports/air-shower-market Browse in-depth TOC on the Air Shower Market103 ?...

at 14:46
Prevent Blindness, the nation's leading eye health and safety organization, applauds the introduction of the "Early Detection of Vision Impairments in Children (EDVI) Act," in the U.S. House of Representatives and urges the 118th Congress to move...

at 14:44
Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to...



News published on and distributed by: